BioSpace News Archive

Advanced Sterilization Products released an interview with experts Ryan Lewis, M.D., Senior Director of Medical Affairs and Medical Safety, and Jeremy Yarwood, Vice President of Research and Development.

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into an amendment of its collaboration, license and option agreement with Aurigene Discovery Technologies, Ltd. (Aurigene)

CosmosID Inc., a leading microbial genomics company focused on standardized, high-resolution microbiome analysis, and Biomeostasis, SAS , a leading pre-clinical CRO that offers in vivo research services in the fields of metabolic & GI diseases, today announced a strategic partnership to provide standa

Vivante Health, the leader in digital medicine for gut health and disease, proudly announced Simon Mathews, M.D. has joined the company as Chief Medical Officer..

Feb. 6, 2020 13:30 UTC IRVINE, Calif.--( BUSINESS WIRE )-- Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that its preliminary unaudited revenue for the fourth quarter ended December 31, 2019 is expected to be approximately $35.8 million. Revenue for the full year ended December 31, 2019 is expected to be approximately $143.4 million.

Kineticos announced today the Kineticos Disruptor Fund , a new life sciences investment fund. The fund will invest in disruptive modalities including cell therapy approches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related precision medicine technologies.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that renowned wellness expert and Certified Nutrition Coach Daniel Miller has joined its subsidiary Kannaway®. Miller, in partnership with Kannaway® as their new spokesperson

New survey reveals fear of health costs exist among residents, despite insurance

JanOne’s lead drug clinical candidate TV1001SR to treat PAD and associated pain will be manufactured by CoreRX Pharma with phase 2b trials expected to begin Q4 2020

The Vegetation Management business within Bayer CropScience LP, announces the label for its latest product. Invora ™ Herbicide has received federal approval from the U.S. Environmental Protection Agency (EPA). The herbicide is federally registered for use on privately-owned, non-hayed rangeland